FAS and pulmonary arterial hypertension: We propose that C75 treatment can reverse PAH pathogenesis through regulating collagen contents, cell proliferation, cell cycle, and anti-inflammatory, thus inhibition of FAS may serve as a potential means for reversing PAH.